GlassScriptPhysician profile
Katherine Hilsinger
NPI 1871584631
$9,718.84
in general payments reported to CMS, 2019-2025
32 companies · $6,615 in 2025
The $6,615 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2020: $859 · 2021: $930 · 2022: $317 · 2023: $20.03 · 2025: $6,615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,615 · Food and Beverage: $20.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,615.00 |
| Food and Beverage | $20.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Plasma INC. | $6,615.00 | 2025 | |
| Abbvie INC. | $675.68 | 2019-2022 | |
| Astellas Pharma US INC | $657.38 | 2019-2022 | |
| Novo Nordisk INC | $223.93 | 2019-2022 | |
| Daiichi Sankyo INC. | $220.25 | 2019-2022 | |
| Therapeuticsmd, INC. | $172.27 | 2019-2021 | |
| Myovant Sciences INC. | $149.64 | 2021-2022 | |
| Amgen INC. | $127.45 | 2019-2021 | |
| Medtronic, INC. | $117.84 | 2021 | |
| Medtronic USA, INC. | $91.94 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $80.91 | 2019-2020 | |
| Allergan, INC. | $67.98 | 2019-2020 | |
| Urovant Sciences INC | $51.18 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $36.40 | 2021-2022 | |
| Axonics, INC. | $36.33 | 2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $35.66 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.91 | 2021 | |
| Amag Pharmaceuticals, INC. | $30.74 | 2019 | |
| Lupin INC. | $30.10 | 2019 | |
| Pfizer INC. | $27.87 | 2019 | |
| Vertical Pharmaceuticals, LLC | $27.85 | 2019 | |
| Minerva Surgical, INC | $26.80 | 2019 | |
| Davol INC. | $22.84 | 2022 | |
| Teleflex LLC | $21.93 | 2021 | |
| Evofem Biosciences, INC. | $21.79 | 2021 | |
| Tesaro, INC. | $20.09 | 2019 | |
| Indivior INC. | $20.03 | 2023 | Sublocade |
| Agile Therapeutics, INC. | $18.04 | 2021 | |
| Organon LLC | $18.00 | 2021 | |
| Hologic Sales and Service, LLC | $14.64 | 2019 | |
| Exeltis, USA INC. | $14.31 | 2019 | |
| Covidien LP | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Hilsinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.